SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-007517
Filing Date
2019-02-14
Accepted
2019-02-14 06:10:08
Documents
22
Period of Report
2019-02-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv512902_8k.htm 8-K 17552
2 EXHIBIT 99.1 tv512902_ex99-1.htm EX-99.1 24533
3 GRAPHIC ex99x1_001.jpg GRAPHIC 39487
4 GRAPHIC ex99x1_002.jpg GRAPHIC 162864
5 GRAPHIC ex99x1_003.jpg GRAPHIC 94038
6 GRAPHIC ex99x1_004.jpg GRAPHIC 61028
7 GRAPHIC ex99x1_005.jpg GRAPHIC 87140
8 GRAPHIC ex99x1_006.jpg GRAPHIC 98997
9 GRAPHIC ex99x1_007.jpg GRAPHIC 88842
10 GRAPHIC ex99x1_008.jpg GRAPHIC 105209
11 GRAPHIC ex99x1_009.jpg GRAPHIC 114161
12 GRAPHIC ex99x1_010.jpg GRAPHIC 96632
13 GRAPHIC ex99x1_011.jpg GRAPHIC 55600
14 GRAPHIC ex99x1_012.jpg GRAPHIC 58277
15 GRAPHIC ex99x1_013.jpg GRAPHIC 52912
16 GRAPHIC ex99x1_014.jpg GRAPHIC 74630
17 GRAPHIC ex99x1_015.jpg GRAPHIC 135877
18 GRAPHIC ex99x1_016.jpg GRAPHIC 79763
19 GRAPHIC ex99x1_017.jpg GRAPHIC 125676
20 GRAPHIC ex99x1_018.jpg GRAPHIC 62017
21 GRAPHIC ex99x1_019.jpg GRAPHIC 82550
22 GRAPHIC ex99x1_020.jpg GRAPHIC 39487
  Complete submission text file 0001144204-19-007517.txt   2408433
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 19600406
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1